UEG - United European Gastroenterology

Author

Manuel Barreiro de Acosta ¹

¹ University

CORRELATION BETWEEN THE PRESENCE OF BACTEROIDETES AND FAECAL CALPROTECTIN FOR THE DETECTION OF ENDOSCOPIC ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Baston-Rey, Rosa A Sueiro, Manuel Barreiro de Acosta, Laura Uribarri González, Rocio Ferreiro Iglesias, José M leiro, Juan Enrique Dominguez-Munoz

Correlation between the presence of Bacteroidetes and faecal calprotectin for the detection of endoscopic activity in patients with inflammatory bowel disease

Manuel Barreiro de Acosta

ASSESSMENT OF BACTEROIDETES GENOTYPES IN BIOPSIES OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS. A CASE-CONTROL STUDY

Manuel Barreiro de Acosta, Rosana Sueiro, Ana Paula De Felipe, Laura Uribarri González, Rocío Ferreiro-Iglesias, José Manuel Leiro, Juan Enrique Dominguez-Munoz

Association of bacteroidetes with endoscopic activity in patients with inflammatory bowel disease (IBD)

Manuel Barreiro de Acosta

ANTI-TNF THERAPY IN ULCERATIVE COLITIS. SHOULD WE REMOVE 5-ASA?

Manuel Barreiro de Acosta

ANTI-TNF THERAPY IN ULCERATIVE COLITIS. SHOULD WE REMOVE 5-ASA?

Manuel Barreiro de Acosta, Iria Baston, Daniel De la Iglesia, Rocío Ferreiro, Aurelio Lorenzo, Juan Enrique Dominguez-Munoz

A PROSPECTIVE OBSERVATIONAL COHORT STUDY TO EVALUATE MUCOSAL HEALING IN ULCERATIVE COLITIS: HAVE MAYO 1 AND MAYO 0 SCORES REALLY THE SAME PROGNOSTIC VALUE?

Manuel Barreiro de Acosta, Nicolau Vallejo Senra, Daniel De la Iglesia-García, Laura Uribarri González, Iria Baston-Rey, Rocío Ferreiro-Iglesias, Aurelio Lorenzo-González, Juan Enrique Dominguez-Munoz

ARE TROUGH LEVELS OF ANTI-TNF DRUGS RELATED WITH TREATMENT FAILURE AND DURATION OF TREATMENT?

Manuel Barreiro de Acosta

CHARACTERIZATION OF BACTEROIDETES ASSOCIATED WITH INTESTINAL MICROBIOTA IN PATIENTS WITH CROHN'S DISEASE AND ANALYSIS OF ITS EFFECT IN THE INDUCTION OF INTESTINAL INFLAMMATION IN MICE

Manuel Barreiro de Acosta

Item 1 - 10 / 45

1

2 3 4 5